Gilead Sciences, Inc. v. Sigmapharm Labs
Gilead Sciences, Inc. v. Sigmapharm Labs
Opinion
NOTE: This disposition is nonprecedential.
United States Court of Appeals for the Federal Circuit ______________________ GILEAD SCIENCES, INC., Plaintiff-Appellee, v. SIGMAPHARM LABORATORIES, LLC, Defendant-Appellant. ______________________ 2014-1456 ______________________ Appeal from the United States District Court for the District of New Jersey in No. 2:10-cv-04931-SDW-MCA, Judge Susan D. Wigenton. ______________________ JUDGMENT ______________________ TIMOTHY J. KELLY, Fitzpatrick, Cella, Harper & Scin- to, of New York, New York, argued for plaintiff-appellee.
With him on the brief was CHRISTOPHER E. LOH. Of counsel was COLLEEN TRACY.
JOHN E. ROSENQUIST, Leydig, Voit & Mayer, LTD., of Chicago, Illinois, argued for defendant-appellant. With him on the brief was MARC R. WEZOWSKI. Of counsel on the brief were K. LEE MARSHALL and ROBERT L.
STOLEBARGER, Bryan Cave LLP, of San Francisco, Cali- fornia; and AMEER GADO and ANTHONY FRIEDMAN, of St. Louis, Missouri. Of counsel was KAREN A. CONFOY, Fox Rothschild, of Lawrenceville, New Jersey. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:
PER CURIAM (DYK, REYNA, and HUGHES, Circuit Judg- es).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
December 8, 2014 /s/ Daniel E. O’Toole Date Daniel E. O’Toole Clerk of Court
Case-law data current through December 31, 2025. Source: CourtListener bulk data.